SoFi Next 500
ALTAR
Score™
5.8% info Recommen-
dation
NEUTRAL
2019E    2020E
P/E
ratio
20.3x P/Sales
ratio
1.6x
P/BV
ratio
2.3x Div.
yield
1.7%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
The SoFi Next 500 ETF seeks to track the performance, before fees and expenses, of the Solactive SoFi US Next 500 Growth Index

FUND BASICS
Category US Equities
Fund Sponsor SoFi
Website www.sofi.com/invest/etfs/
Inception date Apr 10, 2019
Assets (mns) $8
Currency USD
Expense ratio 0 bp
Distributions Quarterly

FUND STRUCTURE
Regulation Open-Ended Fund
Custodian
Weighting Fundamental
Index replication
Uses derivatives No
Options available No

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 494
Wgt avg mkt cap (mns) $6,910
Large cap (>$10bn) 14.2%
Mid cap ($2-10bn) 84.5%
Small cap (<$2bn) 1.3%
Developed mkts 100.0%
Emerging mkts 0.0%

TOP TEN HOLDINGS
ALTICE USA, INC. CLASS A 1.0 %
SEATTLE GENETICS INC 0.7 %
EXACT SCIENCES CORP 0.7 %
DEXCOM INC 0.7 %
VICI PROPERTIES INC 0.7 %
KNIGHT-SWIFT TRANSPORTATION HOLDIN 0.6 %
PAYCOM SOFTWARE INC 0.6 %
SAREPTA THERAPEUTICS INC 0.6 %
ROKU, INC. CLASS A 0.6 %
DOCUSIGN, INC. 0.6 %
Total 6.6 %

TOP COUNTRY EXPOSURE
UNITED STATES 96.4 %
IRELAND 1.0 %
BERMUDA 1.0 %
BRITAIN 0.7 %
NETHERLANDS 0.4 %
CAYMAN ISLANDS 0.2 %
SWITZERLAND 0.1 %




HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru October 31)
Year-to-date 1 year 5 years 10 years Since Incep.
-0.6% -- -- -- -0.6%

Market Correlations
versus... Beta R-squared
S&P500 -- --
MSCI EAFE -- --
MSCI Emg. Mkts. -- --

Technical Indicators
Recent close $10.32
30d moving avg. $10.14
Annualized volatility 0.0%
Short interest (ETF) 0.6%
Relative strength (RSI) 70

Liquidity measures
Avg. volume (thou.) 4
Turnover 0.5%
Bid/Ask (% of price) 0.27%
ADV underlying (mns) $26,474

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the SoFi Next 500 ETF based on the alternatives' overlap in portfolio holdings with SFYX. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: SFYX Expense: 0 bp ALTAR Score™: 5.8%


ALTERNATIVE ETFs BASED ON OVERLAP WITH SFYX
Ticker Fund
Name
Overlap1
vs SFYX
(%)
Expense
ratio
(bp)
Savings
vs SFYX
(bp)
ALTAR
Score™
(%)
ALTAR
vs SFYX
(%)
SCHM Schwab US Mid Cap 68.2 4 -4 6.4 +0.6
OSIZ Invesco Russell 1000 Size Factor ETF 57.7 19 -19 6.3 +0.6
VB Vanguard Smallcap ETF 55.7 5 -5 5.7 -0.1
EZM WisdomTree Midcap Earnings 49.1 38 -38 7.9 +2.1
PBSM Invesco PureBeta MSCI USA Small Cap 48.6 6 -6 5.3 -0.5
IJH iShares Core S&P MidCap 48.5 7 -7 6.4 +0.7
MDY S&P MidCap 400 SPDR 48.5 24 -24 6.2 +0.5
FNX First Trust Mid Cap Core Alpadex 48.2 62 -62 6.8 +1.1
IVOO Vanguard S&P Mid-Cap 400 48.1 15 -15 6.4 +0.6
FSMD Fidelity Small-Mid Factor ETF 47.9 29 -29 6.6 +0.8
SMMD iShares Russell 2500 47.6 15 -15 5.8 +0.0
EWMC Invesco S&P Mid Cap 400 Equal Weight 46.8 40 -40 6.8 +1.1
SPMD SPDR Portfolio Mid Cap 46.7 5 -5 6.4 +0.6
RNMC First Trust Mid Cap US Equity Select 45.8 60 -60 6.8 +1.0
VXF Vanguard Extended Market 44.7 7 -7 3.4 -2.3
DON WisdomTree Midcap Dividend 42.5 38 -38 7.1 +1.4
JHMM John Hancock Multifactor Mid Cap 41.3 44 -44 6.0 +0.2
ESML iShares MSCI USA Small-Cap ESG Optimized 40.1 17 -17 4.9 -0.9
VBK Vanguard Small-Cap Growth ETF 39.9 7 -7 2.9 -2.9
PSM Principal U.S. Small-MidCap Multi-Factor Core Index 39.2 20 -20 6.3 +0.6

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2014 2015 2016 2017 2018 2019E 2020E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2018 2019E 2020E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
SoFi Next 500
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

NEUTRAL

Average appreciation potential. A rating of NEUTRAL is assigned to ETFs with ALTAR Scores in the middle quintile (ranking between 40%-60%) of their category. This indicates that valuations adequately reflect the fundamentals of stocks in these funds.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 12.3 %
Divided by: Fwd. P/BV 2.1 x
Less: Expense ratio 0 bp
Equals: ALTAR Score 5.8 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.54 CATEGORY
AVERAGE
1.55
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.